secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNO Financial Group, Inc. (CNO)
CIK:        0001224608
Form:       8-K
Filed at:   2023-11-13T23:59:59+00:00
Accession:  0001224608-23-000067
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.03, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CNO extends CEO Bhojwani's contract to 2028 and renews poison pill through 2026
-------------------------------------------------------------------------------

- CEO Gary C. Bhojwani employment term extended to April 1, 2028 with auto-renewal provisions.
- Fifth Amended Section 382 Rights Agreement extends poison pill to November 13, 2026 to protect NOLs.
- Rights Agreement purchase price set at $110.00 per one-thousandth of Series F Preferred Stock.
- Rights Agreement requires shareholder approval at 2024 annual meeting; otherwise expires Nov 10, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1224608/000122460823000067/0001224608-23-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1224608/000122460823000067/cno-20231110.htm
  HTML page:      https://secwatch.observer/filing/0001224608-23-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer